Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
6.61
-0.53 (-7.42%)
At close: Dec 4, 2024, 4:00 PM
6.51
-0.10 (-1.51%)
After-hours: Dec 4, 2024, 7:56 PM EST
Senti Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 10.48 | 35.93 | 57.62 | 56.03 | 30.54 | 5.3 |
Short-Term Investments | 0.36 | 0.04 | 42.15 | 1.16 | 0.03 | 12.53 |
Cash & Short-Term Investments | 10.84 | 35.97 | 99.77 | 57.19 | 30.56 | 17.83 |
Cash Growth | -72.97% | -63.95% | 74.45% | 87.13% | 71.42% | - |
Accounts Receivable | 0.07 | 0.11 | 0.63 | 0.48 | 0.32 | 0.08 |
Other Receivables | 1.11 | 17.59 | - | - | - | - |
Receivables | 1.19 | 17.7 | 0.63 | 0.48 | 0.32 | 0.08 |
Prepaid Expenses | 5.35 | 17.33 | 1.87 | 0.8 | - | 0.85 |
Other Current Assets | 0.01 | 0.2 | 0.31 | 1.72 | 0.83 | - |
Total Current Assets | 17.38 | 71.2 | 102.58 | 60.19 | 31.71 | 18.76 |
Property, Plant & Equipment | 36.69 | 41.61 | 69.78 | 33.08 | 16.14 | 16.59 |
Other Long-Term Assets | 3.65 | 6.67 | 8.43 | 3.43 | 0.5 | 0.5 |
Total Assets | 57.72 | 119.48 | 180.79 | 96.7 | 48.35 | 35.84 |
Accounts Payable | 0.79 | 1.25 | 1.37 | 5.19 | 0.91 | 1.2 |
Accrued Expenses | 2.98 | 5.93 | 12.58 | 5.33 | 2 | 1.71 |
Current Portion of Leases | 4.59 | 4.13 | 1.99 | 1.74 | 1.52 | 1.24 |
Current Unearned Revenue | 0.64 | 0.99 | 0.8 | 1.66 | - | 0.17 |
Other Current Liabilities | 0.07 | 0.38 | 1.32 | 0.63 | 0.44 | - |
Total Current Liabilities | 9.06 | 12.67 | 18.05 | 14.54 | 4.87 | 4.31 |
Long-Term Leases | 30.12 | 33.54 | 35.1 | 20.99 | 12.53 | 13.57 |
Long-Term Unearned Revenue | - | - | - | 0.18 | - | - |
Other Long-Term Liabilities | 2.54 | 6.36 | 0.37 | 0.62 | - | - |
Total Liabilities | 41.73 | 52.57 | 53.53 | 36.33 | 17.4 | 17.88 |
Common Stock | 0 | 0.01 | 0 | - | 0 | 0 |
Additional Paid-In Capital | 312.52 | 311.25 | 300.54 | 3.62 | 1.04 | 0.44 |
Retained Earnings | -296.52 | -244.34 | -173.29 | -115.08 | -59.76 | -39.9 |
Comprehensive Income & Other | - | - | 0 | - | - | 0.01 |
Total Common Equity | 15.99 | 66.91 | 127.26 | -111.46 | -58.71 | -39.44 |
Shareholders' Equity | 15.99 | 66.91 | 127.26 | 60.38 | 30.95 | 17.97 |
Total Liabilities & Equity | 57.72 | 119.48 | 180.79 | 96.7 | 48.35 | 35.84 |
Total Debt | 34.71 | 37.67 | 37.09 | 22.73 | 14.05 | 14.81 |
Net Cash (Debt) | -23.87 | -1.7 | 62.68 | 34.46 | 16.51 | 3.02 |
Net Cash Growth | - | - | 81.89% | 108.68% | 446.97% | - |
Net Cash Per Share | -5.25 | -0.38 | 24.01 | 118.33 | 11.91 | 2.22 |
Filing Date Shares Outstanding | 4.59 | 4.57 | 4.42 | 1.52 | 1.45 | 1.36 |
Total Common Shares Outstanding | 4.59 | 4.57 | 4.41 | 1.52 | 1.45 | 1.36 |
Working Capital | 8.32 | 58.53 | 84.53 | 45.65 | 26.84 | 14.45 |
Book Value Per Share | 3.49 | 14.64 | 28.88 | -73.38 | -40.48 | -29.03 |
Tangible Book Value | 15.99 | 66.91 | 127.26 | -111.46 | -58.71 | -39.44 |
Tangible Book Value Per Share | 3.49 | 14.64 | 28.88 | -73.38 | -40.48 | -29.03 |
Machinery | 8.2 | 8.87 | 8.56 | 5.54 | 3.91 | 3.34 |
Construction In Progress | - | - | 43.89 | 8.05 | 0.23 | - |
Leasehold Improvements | 22.65 | 22.65 | 1.87 | 0.43 | 0.16 | 0.15 |
Source: S&P Capital IQ. Standard template. Financial Sources.